Company profile for Hanall Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We study with innovativeness to fulfill your needs. World’s Best Biopharma for R&D of New Innovative Medicine Respectful Pharmaceutical Company to Contribute to Health of the World and to Lead Health Improvement of Mankind. We contribute to cure diseases by developing new medicines.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
Daewoong Building 3F, 12 Bongeunsa-ro 114-gil, Gangnam-gu, Seoul
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/hanall-biopharma-announces-orphan-drug-designation-for-batoclimab-in-japan-for-active-thyroid-eye-disease-302393920.html

PR NEWSWIRE
06 Mar 2025

https://www.prnewswire.com/news-releases/hanall-biopharma-daewoong-pharmaceutical-and-nurron-pharmaceuticals-announce-successful-completion-of-a-first-in-human-study-for-potential-disease-modifying-therapy-for-parkinsons-disease-302315158.html

PR NEWSWIRE
25 Nov 2024

https://www.prnewswire.com/news-releases/hanall-biopharma-reports-q3-2024-financial-results-and-provides-business-update-302293804.html

PR NEWSWIRE
01 Nov 2024

https://www.prnewswire.com/news-releases/hanall-biopharma-reports-q2-2024-financial-results-and-provides-business-update-302207336.html

PR NEWSWIRE
26 Jul 2024

https://www.prnewswire.com/news-releases/hanall-biopharma-appoints-christopher-w-slavinsky-as-chief-business-development-and-legal-officer-302196473.html

PR NEWSWIRE
15 Jul 2024

https://www.prnewswire.com/news-releases/hanall-biopharma-signs-licensing-agreement-with-turn-biotechnologies-to-develop-novel-treatments-for-eye-and-ear-diseases-302156468.html

PR NEWSWIRE
28 May 2024

ABOUT THIS PAGE

Contact Hanall Biopharma and get a quotation

Hanall Biopharma is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Cefoperazone Sodium bulk offered by Hanall Biopharma

Find a price of Fudosteine bulk offered by Hanall Biopharma

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty